GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Eidos Therapeutics Inc (FRA:6MX) » Definitions » Accounts Payable

Eidos Therapeutics (FRA:6MX) Accounts Payable : €2.02 Mil (As of Sep. 2020)


View and export this data going back to 2018. Start your Free Trial

What is Eidos Therapeutics Accounts Payable?

Eidos Therapeutics's Accounts Payable for the quarter that ended in Sep. 2020 was €2.02 Mil.

Eidos Therapeutics's quarterly Accounts Payable declined from Mar. 2020 (€3.60 Mil) to Jun. 2020 (€1.99 Mil) but then increased from Jun. 2020 (€1.99 Mil) to Sep. 2020 (€2.02 Mil).

Eidos Therapeutics's annual Accounts Payable increased from Dec. 2017 (€0.48 Mil) to Dec. 2018 (€1.72 Mil) and increased from Dec. 2018 (€1.72 Mil) to Dec. 2019 (€2.84 Mil).


Eidos Therapeutics Accounts Payable Historical Data

The historical data trend for Eidos Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eidos Therapeutics Accounts Payable Chart

Eidos Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19
Accounts Payable
0.09 0.48 1.72 2.84

Eidos Therapeutics Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.24 2.84 3.60 1.99 2.02

Eidos Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Eidos Therapeutics Accounts Payable Related Terms

Thank you for viewing the detailed overview of Eidos Therapeutics's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Eidos Therapeutics (FRA:6MX) Business Description

Traded in Other Exchanges
N/A
Address
101 Montgomery Street, Suite 2000, San Francisco, CA, USA, 94104
Eidos Therapeutics Inc is a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. TTR is a protein that occurs naturally in the form of a tetramer and performs multiple beneficial roles, including the transport of essential hormones and vitamins. The company's product candidate, AG10, is an orally-administered small molecule designed to potently stabilize tetrameric TTR.

Eidos Therapeutics (FRA:6MX) Headlines

No Headlines